A pharmacokinetics study of nicotine for B-001 in healthy adult male smokers

A pharmacokinetics study of nicotine for B-001 in healthy adult male smokers - A pharmacokinetics study for B-001

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017297

Enrollment

Registered

2016-11-21

Start date

2015-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smokers

Interventions

Period1:Use of B-001 - Period2:Use of CC1 Period1:Use of CC1 - Period2:Use of B-001

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: - Subjects who sign the study-specific consent form - Subjests who are confirmed to be in good health through the screening process - Smokers etc.

Exclusion criteria

Exclusion criteria: - Subjects who have used smoking cessation medications within 4 weeks of the screening, or plan to use the medication until the end of the study - Subjects whose blood was collected more than 200 ml within 4 weeks prior to the screening, or more than 400 ml within 12weeks prior to the screening (including blood donation) etc.

Design outcomes

Primary

Measure	Time frame
Nicotine pharmacokinetic parameters (Cmax, Tmax and AUClast)	—

Countries

Japan

Contacts

Public ContactAki Nonaka

JAPAN TOBACCO INC. Scientific Product Assessment Center, Tobacco Business Headquarters

aki.nonaka@jt.com045-973-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026